Demographic, etiological, clinical features, and laboratory features of hepatocellular carcinoma; a single center experience
Abstract
Objective: Hepatocellular carcinoma (HCC) is our country's most commonly encountered cancer. This study examined demographic, etiologic, clinical characteristics, and biochemical and serological findings of patients with HCC.
Methods: We retrospectively analyzed 207 HCC patients followed by gastroenterology and medical oncology departments.
Results: It was established that, in the demographic analysis, HCC was more common in the elderly population, especially in men. The positive hepatitis B virus surface antigen rate was 65.5%, anti-delta was 2%, and hepatitis C virus antibody was determined to be 15%. The rate of alcohol users was 11.1%, and that of tobacco users was 68.2%. Serum alkaline phosphatase, gamma-glutamyl transferase, and serum alpha-fetoprotein (AFP) levels were above average in 75.6%, 86.3%, and 72.6% of patients, respectively. Approximately 63% of patients had cirrhosis at presentation. Ultrasonography (USG) was the primary diagnostic method in 57% of the patients. Histopathological diagnosis was made by ultrasound-guided biopsy in 67.6% of the patients.
Conclusion: Chronic hepatitis B was the most common etiological factor for HCC, and chronic hepatitis C was observed at a significant rate of %15. The majority of the patients developed HCC on the cirrhotic ground. Most of the patients had high levels of AFP. In 58% of patients, the tumor was located in the right lobe. Routine liver tests and clinical findings varied. Radiologically, it was concluded that USG, computed tomography, and magnetic resonance imaging techniques were complementary and equivalent methods in terms of tumor diameter.
Keywords
Hepatocellular carcinoma, Hepatitis B virus, Hepatitis C virus, Alpha-fetoprotein
References
- Parkin DM. Global cancer statistics in the year 2000. Lancet Oncol. 2001;2(9):533-43 DOI: 10.1016/s1470-2045(01)00486-7.
- McMahon BJ, Alberts SR, Wainwright RB, Bulkow L, Lanier AP. Hepatitis B-related sequelae. Prospective study in 1400 hepatitis B surface antigen-positive Alaska native carriers. Arch Intern Med. 1990;150(5):1051-4 DOI: 10.1001/archinte.150.5.1051.
- Sugano S, Miyoshi K, Suzuki T, Kawafune T, Kubota M. Intrahepatic arteriovenous shunting due to hepatocellular carcinoma and cirrhosis, and its change by transcatheter arterial embolization. Am J Gastroenterol. 1994;89(2):184-8 https://pubmed.ncbi.nlm.nih.gov/8304300/
- MC. K. Tumors of the liver. In: Zakim D. BT, editor. HEPATOLOGY: A TEXTBOOK OF THE LİVER DİSEASE. PHILADELPHIA: WB Saunders Company; 1996. p. 1513.
- Lai CL, Ng RP, Lok AS. The diagnostic value of the ratio of serum gamma-glutamyl transpeptidase to alkaline phosphatase in alcoholic liver disease. Scand J Gastroenterol. 1982;17(1):41-7 DOI: 10.3109/00365528209181042.
- Yoon KT, Kim JK, Kim DY, Ahn SH, Lee JD, Yun M, et al. Role of 18FFluorodeoxyglucose Positron Emission Tomography in Detecting Extrahepatic Metastasis in Pretreatment Staging of Hepatocellular Carcinoma. Oncology. 2007;72(suppl 1)(Suppl. 1):10410 DOI: 10.1159/000111715.
- Yuki K, Hirohashi S, Sakamoto M, Kanai T, Shimosato Y. Growth and spread of hepatocellular carcinoma. A review of 240 consecutive autopsy cases. Cancer. 1990;66(10):2174-9 DOI: 10.1002/1097 0142(19901115)66:10<2174::aidcncr2820661022>3.0.co;2-a.
- Kew MC, Dos Santos HA, Sherlock S. Diagnosis of primary cancer of the liver. Br Med J. 1971;4(5784):408-11 DOI: 10.1136/bmj.4.5784.408.
- Llovet JM, Bustamante J, Castells A, Vilana R, Ayuso Mdel C, Sala M, et al. Natural history of untreated nonsurgical hepatocellular carcinoma: rationale for the design and evaluation of therapeutic trials. Hepatology. 1999;29(1):62-7 DOI: 10.1002/hep.510290145.
- A new prognostic system for hepatocellular carcinoma: a retrospective study of 435 patients: the Cancer of the Liver Italian Program (CLIP) investigators. Hepatology. 1998;28(3):751-5 DOI: 10.1002/hep.510280322.
